ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS

Company Information

Company Name
ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS
Address
9924 Mesa Rim Road
SAN DIEGO, CA, 92121-2910
Phone
n/a
URL
n/a
DUNS
021345447
Number of Employees
n/a
Minority Owned

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$1,575,475.00
10
Chart code to be here

Award List

  1. RNA Resource for Synthetic Lethal Screening of DNA Repair and

    Amount: $199,918.00

    The objectives of this proposal are to develop gene silencing reagents, and to test/validate their use in  synthetic lethal screening of DNA damage signaling and repair pathways. Making such reag ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. EFFICIENT CELL-FREE SELECTION OF ANTIBODIES

    Amount: $99,700.00

    DESCRIPTION: The objective of this proposal is to develop a novel cell-free system that would facilitate rapid selection of functional fragments of monoclonal antibodies. The system desc ...

    SBIR Phase I 2001 Department of Health and Human Services
  3. Novel Technology for Field Detection of Gene Expression

    Amount: $199,341.00

    DESCRIPTION (provided by applicant): The general aim of this proposal is to develop and commercialize an innovative technology for gene expression ...

    SBIR Phase I 2001 Department of Health and Human Services
  4. Innovative RNA Profiling in Cancer Cells

    Amount: $149,500.00

    The ultimate goal of this proposal is to develop and commercialize a novel and powerful assay system for amplification and detection of gene transcripts in cancer-related studies. Specifically, our pr ...

    SBIR Phase I 2001 Department of Health and Human Services
  5. Cell Microarrays for High Throughput RNAi

    Amount: $99,510.00

    DESCRIPTION (provided by applicant): The goal of this proposal is to further develop and adapt our existing DNA-based RNAi technology to a cell microarray format for high throughput gene function stud ...

    SBIR Phase I 2003 Department of Health and Human Services
  6. Advanced Platform of RNAi Technology

    Amount: $99,510.00

    RNA interference (RNAi) is a powerful tool for gene function studies and drug development. Currently, application of this technology is largely limited by the efficiency of delivering RNAi-inducing re ...

    SBIR Phase I 2003 Department of Health and Human Services
  7. SBIR PHASE I, TOPIC 239 YEAST SINGLE CHAIN ANTIBODIES AS CAPTURE REAGENTS

    Amount: $150,000.00

    N/A

    SBIR Phase I 2007 Department of Health and Human Services
  8. Improving Pediatric Developmental Screening and Communication: A CME

    Amount: $199,939.00

    DESCRIPTION (provided by applicant): The goal of the proposed project is to develop a commercial kit that will allow drug addiction researchers with ongoing projects using cell-based models to be able ...

    SBIR Phase I 2013 Department of Health and Human Services
  9. Nano-Antibodies for Studying RNA Modifications

    Amount: $225,000.00

    DESCRIPTION (provided by applicant): The goal of the proposed Phase I research is to develop a set of commercial reagents for recognizing 2'-O-methyladenosine (Am), 2'-O-methylcytidine (Cm), ...

    SBIR Phase I 2014 Department of Health and Human Services
  10. RNA-Guided Gene Targeting in Human Cells

    Amount: $153,057.00

    Project Summary/Abstract The goal of the proposed Phase I research is to develop a set of commercial kits for footprint-free genome engineering. The core technologies that serve as the foundation of t ...

    SBIR Phase I 2014 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government